Swedbank’s Adamas Pharmaceuticals ADMS Stock Holding History

Swedbank’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,485,000	Closed	-$7.29M	–	774
2021 Q3	$7.29M	Hold	1,485,000	–	–	0.01%	512
2021 Q2	$7.84M	Hold	1,485,000	–	–	0.01%	499
2021 Q1	$7.13M	Buy	+1,485,000	New	+$7.75M	0.01%	507

Swedbank's ADMS Position: Q4 2021 in Review

Swedbank sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 1,485,000 shares — an estimated $7.29M sold.

Swedbank first reported a position in ADMS in Q1 2021 and held it in 3 quarters. The position peaked at $7.84M in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Swedbank reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Swedbank sold 1,485,000 Adamas Pharmaceuticals shares in Q4 2021, an estimated $7.29M.
Swedbank first reported a position in Adamas Pharmaceuticals in Q1 2021 and held it in 3 quarters.
Swedbank's Adamas Pharmaceuticals position peaked at $7.84M in Q2 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Swedbank's 13F filing for Q4 2021, filed 6 Dec 2024.